| Dr Julia Beth Hadricky, PSYD | |
|
19000 Homestead Rd, Cupertino, CA 95014-0712 | |
| (813) 382-4844 | |
| Not Available |
| Full Name | Dr Julia Beth Hadricky |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 19000 Homestead Rd, Cupertino, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053685255 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PSY24830 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julia Beth Hadricky, PSYD 19000 Homestead Rd, Cupertino, CA 95014-0712 Ph: (813) 382-4844 | Dr Julia Beth Hadricky, PSYD 19000 Homestead Rd, Cupertino, CA 95014-0712 Ph: (813) 382-4844 |
News Archive
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,759,304, entitled "Targeting Complement Factor H For Treatment of Diseases", covering the composition of matter for its lead product candidate, TT30, a novel fusion protein that selectively binds to complement activated cells to locally regulate the complement system.
Assessing the accuracy and value of an increasingly popular and free online patient management app, researchers at Johns Hopkins Medicine and other institutions say that physicians with more training and experience perform better in selecting appropriate diagnoses for sample patient scenarios.
Peter Roy-Byrne, M.D., formerly of the University of Washington, Seattle, and colleagues write that few data exist on the effectiveness of brief (1-2 sessions) interventions for reducing problem drug use, a common issue in disadvantaged populations seeking care in safety-net medical settings (hospitals and community health clinics serving low-income patients with limited or no insurance).
The GammaPod - a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer - has received 510(k) clearance from the U.S. Food and Drug Administration, paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.
Cordis Corporation today announced that a U.S. District Court jury in Wilmington, Delaware found that Boston Scientific's Taxus drug-eluting stent and its Liberte and Express bare metal stents infringe Cordis' pioneering Palmaz patent for balloon expandable stents
› Verified 2 days ago
Dr. Roger Johnson, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 19000 Homestead Rd, Cupertino, CA 95014 Phone: 408-366-4408 Fax: 408-366-4405 | |
Dr. Steven Aldo Del Chiaro, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 20833 Stevens Creek Blvd Suite 100, Cupertino, CA 95014 Phone: 408-342-0160 | |
Dr. Helen Tait, PH.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 20395 Pacifica Dr Ste 101, Cupertino, CA 95014 Phone: 408-725-8043 Fax: 408-725-8063 | |
Priya Mahurkar, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 20833 Stevens Creek Blvd, Suite 100, Cupertino, CA 95014 Phone: 408-342-0612 Fax: 408-342-0617 | |
Dr. Catherine Mary Marino, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 19000 Homestead Rd, Building 2, Psychiatry Administration Suite, Cupertino, CA 95014 Phone: 650-283-9334 | |
Dr. Martin Howard Williams, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 19000 Homestead Rd, Cupertino, CA 95014 Phone: 408-366-4409 |